Affinia Therapeutics
Expanding what's possible in AAV gene therapy today.
Waltham, United States · Founded 2019 · $210.0M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- affiniatx.com
- Total Funding
- $210.0M
- Last Round
- $40.0M Series COct 2025
- Rounds
- 3
About
Affinia Therapeutics pioneers rationally designed AAV gene therapies for rare and prevalent diseases, focusing on heart and nervous system disorders. Using AI and structural modeling, their ART platform creates novel capsids for improved tissue targeting, safety, and efficacy. Their lead program AFTX-201 targets BAG3-associated dilated cardiomyopathy.
Summary
Affinia Therapeutics is a Biotech company based in Waltham, United States, founded in 2019. It has raised $210.0M in total across 3 rounds, most recently a $40.0M Series C round in Oct 2025. Investors include New Enterprise Associates, F-Prime Capital and EcoR1 Capital.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Oct 2025
Sign up to see all 3 rounds
Series A through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/affinia-therapeutics"><img src="https://indexed.vc/api/badge/company/affinia-therapeutics" alt="Affinia Therapeutics on Indexed.vc" width="260" height="76" /></a>